ANI Pharmaceuticals (NASDAQ:ANIP) Receives Neutral Rating from Cantor Fitzgerald

ANI Pharmaceuticals (NASDAQ:ANIP – Get Rating)‘s stock had its “neutral” rating restated by research analysts at Cantor Fitzgerald in a report released on Wednesday, Zacks.com reports. Other research analysts have also recently issued research reports about the stock. Zacks Investment Research upgraded shares of ANI Pharmaceuticals from a “sell” rating to a “hold” rating in […]

Related Keywords

Raymond James ,Jeanne Thoma ,Thompson Siegel Walmsley ,Zacks Investment Research ,Blackrock Inc ,Pharmaceuticals Company Profile Get Rating ,Cantor Fitzgerald ,William Blair Investment Management ,Pharmaceuticals Inc ,Dimensional Fund Advisors ,Ani Pharmaceuticals ,Get Rating ,Investment Research ,Director Jeanne Thoma ,Blair Investment Management ,Street Corp ,Fund Advisors ,Company Profile ,Nasdaq Anip ,Manip ,Medical ,Reiterated Rating ,